// App-Quantinova.ai

: Exacerbation and pneumonia risk models: methodology and results from the IMPACT trial

Researchers

Presenter

  • Benjamin Hartley

Principal Investigators

  • Sally Lettis

  • David Lipson

  • Paul Jones

  • Courtney Crim

  • Mark Dransfield

  • David Singh

  • Neil Martin

  • Neil Barnes

Medical Centers

  • Veramed Ltd, Twickenham, United Kingdom,

  • GlaxoSmithKline, Uxbridge, United Kingdom

  • GSK and Perelman School of Medicine, University of Pennsylvania, Collegeville and Philadelphia, PA, United States.

  • Glaxo-Smith Kline, Brentford, London, United Kingdom

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • Lung Health Center, University of Alabama at Birmingham, Birmingham, AL, United States,

  • University of Manchester, Manchester, United Kingdom

  • GlaxoSmithKline and University of Leicester, Brentford and Leicester, United Kingdom

  • GlaxoSmithKline and Barts and the London School of Medicine and Dentistry, Brentford, Middlesex and London, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved